Search
Saturday 19 September 2015
  • :
  • :
Latest Update

Pre-Market News Report on: Great Basin Scientific (NASDAQ:GBSN), Xcel Energy (NYSE:XEL), First Niagara Financial Group (NASDAQ:FNFG), Brandywine Realty Trust (NYSE:BDN)

On Tuesday, Great Basin Scientific Inc (NASDAQ:GBSN)’s shares inclined 4.19% to $3.23.

Great Basin Scientific, Inc. ( GBSN), a molecular diagnostics company, recently declared the election of Kirk Calhoun to its Board of Directors, effective May 27, 2015. Mr. Calhoun was elected to the board as an independent director during the Company’s Annual Stockholder Meeting on May 27 in Salt Lake City. He will serve as the chair of the Company’s Audit Committee. Mr. Calhoun joins Ryan Ashton, David Spafford, Ronald K. Labrum and Sam Chawla on the board, and replaces Steven Aldous, who is retiring from his director position .

Mr. Calhoun is a Certified Public Accountant (non-practicing) with a background in auditing and accounting. Mr. Calhoun joined Ernst & Young LLP, a public accounting firm, in 1965 and served as a partner of the firm from 1975 until his retirement in 2002. Mr. Calhoun presently serves on the board and audit committee of Response Genetics, Inc. (RGDX) and Ryerson Holding Corporation (RYI). Mr. Calhoun has served formerly on the boards and audit committees of five public companies in the pharmaceutical industry up until the dates of their respective sales, counting Abraxis Bioscience, Inc., Myogen, Inc., Aspreva Pharmaceuticals Company, Replidyne, Inc. and Adams Respiratory Therapeutics, Inc. Mr. Calhoun also presently serves on the boards of three private companies, counting NeuroSigma, Inc., a developer of products that treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Mr. Calhoun received a B.S. in Accounting from the University of Southern California.

Great Basin Scientific, Inc., a molecular diagnostic testing company, doing business as Great Basin Corporation, develops and commercializes molecular diagnostic systems that are designed to test hospital-attained infections. The company’s platform provides C. diff test, a rapid medical diagnostic test for the detection of C. diff, gram-positive bacteria that causes severe diarrhea and other intestinal disorders. It also provides Group B streptococcus test, which is used to detect Group B streptococcus from an anal/vaginal swab of a pregnant woman.

Xcel Energy Inc (NYSE:XEL)’s shares gained 0.62% to $32.38.

Xcel Energy Inc (XEL)

PROFILE

At the end of Tuesday’s trade, First Niagara Financial Group Inc. (NASDAQ:FNFG)‘s shares surged 1.15% to $9.67.

First Niagara Financial Group Inc. (FNFG) support of programs in community development, as well as youth and education, included 26,000 employee volunteer hours and more than $10 million in charitable giving last year.

The company recently released its 2014 community report, highlighting some of the more than 1,250 non-profit partners, programs and people that First Niagara worked with to enhance communities across New York State, Pennsylvania, Connecticut and Massachusetts.

In addition to First Niagara’s corporate and foundation grants totaling more than $10 million in 2014, the company’s employees donated nearly $450,000 to the United Way’s annual campaign, while local Employee Volunteer Councils held more than 250 events raising more than $110,000 for not-for-profit organizations and causes. The company also accomplished more than $155 million in community development loans to assist spark economic development activities and job creation across its four-state footprint.

First Niagara Financial Group, Inc. operates as the bank holding company for First Niagara Bank, N.A. that provides retail and commercial banking, and other financial services to individuals, families, and businesses. The company’s deposit products comprise savings and money market, and certificate of deposit accounts, in addition to municipal deposits. Its loan portfolio comprise commercial business loans; commercial real estate and multi-family lending products; residential real estate lending products; home equity lending products; indirect automobile lending products; credit cards; and other consumer loans, such as personal secured and unsecured loans, and overdraft lines of credit.

Brandywine Realty Trust (NYSE:BDN), ended its Tuesday’s trading session with -0.44% loss, and closed at $13.60.

Brandywine Realty Trust (BDN) declared that our Board of Trustees has declared a quarterly cash dividend of $0.15 per common share, payable on July 20, 2015 to holders of record on July 6, 2015. The Board of Trustees also declared a quarterly dividend of $0.43125 for each 6.90% Series E Cumulative Redeemable Preferred Share, payable on July 15, 2015 to holders of record on June 30, 2015.

Brandywine Realty Trust is a publically owned real estate investment trust. The firm invests in real estate markets of the United States. It makes investments in office, mixed-use, and industrial properties. Brandywine Realty Trust was founded in 1985 and is based in Radnor, Pennsylvania with additional offices in Mount Laurel, New Jersey; Richmond, Virginia; Dallas, Texas; Falls Church, Virginia; Oakland, California; Austin, Texas, and Carlsbad, California.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.

 




Leave a Reply

Your email address will not be published. Required fields are marked *